Gastrointestinal mucormycosis in immunocompromised hosts

M. Veronica Dioverti, Kelly A. Cawcutt, Maheen Abidi, M. Rizwan Sohail, Randall C. Walker, Douglas R. Osmon

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Invasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non-specific in gastrointestinal disease, leading to delayed therapy. To describe the clinical presentation, diagnosis, treatment and outcomes of gastrointestinal mucormycosis in immunocompromised hosts, we reviewed all cases of primary gastrointestinal mucormycosis in immunocompromised hosts reported in English literature as well as in our Institution from January 1st 1991 to December 31st 2013 for a total of 31 patients. About 52% of patients underwent solid organ transplant (SOT), while the rest had an underlying haematologic malignancy. Abdominal pain was the most common presenting symptom, followed by gastrointestinal bleeding and fever. Gastric disease was more common in SOT, whereas those with haematologic malignancy presented with intestinal disease (P = 0.002). Although gastrointestinal mucormycosis remains an uncommon condition in immunocompromised hosts, it carries significant morbidity and mortality, particularly in cases with intestinal involvement. A high index of suspicion is of utmost importance to institute early and appropriate therapy and improve outcomes.

Original languageEnglish (US)
Pages (from-to)714-718
Number of pages5
JournalMycoses
Volume58
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Mucormycosis
Immunocompromised Host
Gastrointestinal Diseases
Hematologic Neoplasms
Literature
Transplants
Stomach Diseases
Intestinal Diseases
Mortality
Mycoses
Secondary Prevention
Abdominal Pain
Early Diagnosis
Fever
Hemorrhage
Morbidity
Therapeutics

Keywords

  • Fungal infections
  • Immunocompromised
  • Mucormycosis

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Dioverti, M. V., Cawcutt, K. A., Abidi, M., Sohail, M. R., Walker, R. C., & Osmon, D. R. (2015). Gastrointestinal mucormycosis in immunocompromised hosts. Mycoses, 58(12), 714-718. https://doi.org/10.1111/myc.12419

Gastrointestinal mucormycosis in immunocompromised hosts. / Dioverti, M. Veronica; Cawcutt, Kelly A.; Abidi, Maheen; Sohail, M. Rizwan; Walker, Randall C.; Osmon, Douglas R.

In: Mycoses, Vol. 58, No. 12, 01.12.2015, p. 714-718.

Research output: Contribution to journalArticle

Dioverti, MV, Cawcutt, KA, Abidi, M, Sohail, MR, Walker, RC & Osmon, DR 2015, 'Gastrointestinal mucormycosis in immunocompromised hosts', Mycoses, vol. 58, no. 12, pp. 714-718. https://doi.org/10.1111/myc.12419
Dioverti MV, Cawcutt KA, Abidi M, Sohail MR, Walker RC, Osmon DR. Gastrointestinal mucormycosis in immunocompromised hosts. Mycoses. 2015 Dec 1;58(12):714-718. https://doi.org/10.1111/myc.12419
Dioverti, M. Veronica ; Cawcutt, Kelly A. ; Abidi, Maheen ; Sohail, M. Rizwan ; Walker, Randall C. ; Osmon, Douglas R. / Gastrointestinal mucormycosis in immunocompromised hosts. In: Mycoses. 2015 ; Vol. 58, No. 12. pp. 714-718.
@article{e3ed1fca5a954f7cb24341c75e7f1967,
title = "Gastrointestinal mucormycosis in immunocompromised hosts",
abstract = "Invasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non-specific in gastrointestinal disease, leading to delayed therapy. To describe the clinical presentation, diagnosis, treatment and outcomes of gastrointestinal mucormycosis in immunocompromised hosts, we reviewed all cases of primary gastrointestinal mucormycosis in immunocompromised hosts reported in English literature as well as in our Institution from January 1st 1991 to December 31st 2013 for a total of 31 patients. About 52{\%} of patients underwent solid organ transplant (SOT), while the rest had an underlying haematologic malignancy. Abdominal pain was the most common presenting symptom, followed by gastrointestinal bleeding and fever. Gastric disease was more common in SOT, whereas those with haematologic malignancy presented with intestinal disease (P = 0.002). Although gastrointestinal mucormycosis remains an uncommon condition in immunocompromised hosts, it carries significant morbidity and mortality, particularly in cases with intestinal involvement. A high index of suspicion is of utmost importance to institute early and appropriate therapy and improve outcomes.",
keywords = "Fungal infections, Immunocompromised, Mucormycosis",
author = "Dioverti, {M. Veronica} and Cawcutt, {Kelly A.} and Maheen Abidi and Sohail, {M. Rizwan} and Walker, {Randall C.} and Osmon, {Douglas R.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/myc.12419",
language = "English (US)",
volume = "58",
pages = "714--718",
journal = "Mycoses",
issn = "0933-7407",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Gastrointestinal mucormycosis in immunocompromised hosts

AU - Dioverti, M. Veronica

AU - Cawcutt, Kelly A.

AU - Abidi, Maheen

AU - Sohail, M. Rizwan

AU - Walker, Randall C.

AU - Osmon, Douglas R.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Invasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non-specific in gastrointestinal disease, leading to delayed therapy. To describe the clinical presentation, diagnosis, treatment and outcomes of gastrointestinal mucormycosis in immunocompromised hosts, we reviewed all cases of primary gastrointestinal mucormycosis in immunocompromised hosts reported in English literature as well as in our Institution from January 1st 1991 to December 31st 2013 for a total of 31 patients. About 52% of patients underwent solid organ transplant (SOT), while the rest had an underlying haematologic malignancy. Abdominal pain was the most common presenting symptom, followed by gastrointestinal bleeding and fever. Gastric disease was more common in SOT, whereas those with haematologic malignancy presented with intestinal disease (P = 0.002). Although gastrointestinal mucormycosis remains an uncommon condition in immunocompromised hosts, it carries significant morbidity and mortality, particularly in cases with intestinal involvement. A high index of suspicion is of utmost importance to institute early and appropriate therapy and improve outcomes.

AB - Invasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non-specific in gastrointestinal disease, leading to delayed therapy. To describe the clinical presentation, diagnosis, treatment and outcomes of gastrointestinal mucormycosis in immunocompromised hosts, we reviewed all cases of primary gastrointestinal mucormycosis in immunocompromised hosts reported in English literature as well as in our Institution from January 1st 1991 to December 31st 2013 for a total of 31 patients. About 52% of patients underwent solid organ transplant (SOT), while the rest had an underlying haematologic malignancy. Abdominal pain was the most common presenting symptom, followed by gastrointestinal bleeding and fever. Gastric disease was more common in SOT, whereas those with haematologic malignancy presented with intestinal disease (P = 0.002). Although gastrointestinal mucormycosis remains an uncommon condition in immunocompromised hosts, it carries significant morbidity and mortality, particularly in cases with intestinal involvement. A high index of suspicion is of utmost importance to institute early and appropriate therapy and improve outcomes.

KW - Fungal infections

KW - Immunocompromised

KW - Mucormycosis

UR - http://www.scopus.com/inward/record.url?scp=84946834881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946834881&partnerID=8YFLogxK

U2 - 10.1111/myc.12419

DO - 10.1111/myc.12419

M3 - Article

C2 - 26456920

AN - SCOPUS:84946834881

VL - 58

SP - 714

EP - 718

JO - Mycoses

JF - Mycoses

SN - 0933-7407

IS - 12

ER -